Cargando…
Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy
RATIONALE: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initia...
Autores principales: | Bloom, Chloe I., Graham, Christine M., Berry, Matthew P. R., Wilkinson, Katalin A., Oni, Tolu, Rozakeas, Fotini, Xu, Zhaohui, Rossello-Urgell, Jose, Chaussabel, Damien, Banchereau, Jacques, Pascual, Virginia, Lipman, Marc, Wilkinson, Robert J., O’Garra, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462772/ https://www.ncbi.nlm.nih.gov/pubmed/23056259 http://dx.doi.org/10.1371/journal.pone.0046191 |
Ejemplares similares
-
Identification of the Key Differential Transcriptional Responses of Human Whole Blood Following TLR2 or TLR4 Ligation In-Vitro
por: Blankley, Simon, et al.
Publicado: (2014) -
Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis
por: McNab, Finlay W, et al.
Publicado: (2011) -
Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
por: Bloom, Chloe I., et al.
Publicado: (2013) -
Correction: Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
por: Bloom, Chloe I., et al.
Publicado: (2013) -
The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis
por: Blankley, Simon, et al.
Publicado: (2016)